Related Experiment Video
Updated: Jan 26, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
Dawn of precision medicine on gastric cancer
Takahiro Ishii1, Akihito Kawazoe1, Kohei Shitara2
1Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Background:
In recent years, a better understanding of tumor biology and molecular features of gastric cancer has been reached. It may serve as a roadmap for patient stratification and trials of targeted therapies. The apparent efficacy of PD-1 blockade might be limited to a relatively small subset of advanced gastric cancer patients.
Materials And Methods:
In this study, preclinical and clinical studies, which investigated molecular features, promising treatment targets, and immune checkpoint inhibitor in gastric cancer, were reviewed via PubMed and the congress webpages of the American Society of Clinical Oncology and European Society of Medical Oncology.
Results:
Next-generation sequencing technologies have defined the genomic landscape of gastric cancer. Indeed, several molecular classifications have been proposed, and distinct molecular subtypes have been identified. Based on these molecular profiles, clinical trials of new agents such as receptor tyrosine kinases inhibitors, antibody-drug conjugates, and IMAB362 (anti-Claudin 18.2) are ongoing. In addition, biomarkers to predict response during immune checkpoint inhibitors and combination therapy have been enthusiastically investigated.
Conclusion:
Remarkable advances in an understanding of molecular profiles of gastric cancer enable the development of novel agents. The better treatment selection of immune checkpoint inhibitors or combination therapy should be established. These developments could facilitate precision medicine on gastric cancer in the near future.
Insights
Advances in understanding gastric cancer biology are guiding targeted therapies and immune checkpoint inhibitors. Further research aims to improve treatment selection for precision medicine in gastric cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Recent progress has improved understanding of gastric cancer biology and molecular features.
- This knowledge aids in patient stratification and the development of targeted therapies.
- The effectiveness of PD-1 blockade is currently limited to a subset of advanced gastric cancer patients.
Purpose of the Study:
- To review preclinical and clinical studies on molecular features, treatment targets, and immune checkpoint inhibitors in gastric cancer.
- To explore the potential for novel therapeutic strategies and biomarkers in gastric cancer.
Main Methods:
- Literature review of studies indexed in PubMed.
- Analysis of congress webpages from the American Society of Clinical Oncology and European Society of Medical Oncology.
- Focus on molecular features, targeted therapies, and immune checkpoint inhibitors in gastric cancer.
Main Results:
- Next-generation sequencing has elucidated the genomic landscape of gastric cancer, leading to proposed molecular classifications and identified subtypes.
- Clinical trials are underway for novel agents including receptor tyrosine kinase inhibitors, antibody-drug conjugates, and IMAB362 (anti-Claudin 18.2).
- Biomarkers for predicting response to immune checkpoint inhibitors and combination therapies are under active investigation.
Conclusions:
- Advances in understanding molecular profiles facilitate the development of novel gastric cancer agents.
- Improved treatment selection for immune checkpoint inhibitors and combination therapies is crucial.
- These developments pave the way for precision medicine in gastric cancer.
Related Concept Videos
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Gastric Emptying
Gastric Phase of Digestion
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
Uncertainty in Measurement: Accuracy and Precision
Microorganisms in Medicine and Therapeutics
Accuracy and Precision

